NM_000925.4(PDHB):c.1069T>C (p.Leu357=) AND Pyruvate dehydrogenase E1-beta deficiency

Clinical significance:Conflicting interpretations of pathogenicity, Likely benign(1);Uncertain significance(1) (Last evaluated: Sep 3, 2020)

Review status:1 star out of maximum of 4 stars

criteria provided, conflicting interpretations

Based on:
2 submissions [Details]
Record status:
current
Accession:
RCV001144884.2

Allele description [Variation Report for NM_000925.4(PDHB):c.1069T>C (p.Leu357=)]

NM_000925.4(PDHB):c.1069T>C (p.Leu357=)

Gene:
PDHB:pyruvate dehydrogenase E1 subunit beta [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3p14.3
Genomic location:
Preferred name:
NM_000925.4(PDHB):c.1069T>C (p.Leu357=)
HGVS:
  • NC_000003.12:g.58428045A>G
  • NG_016860.1:g.10808T>C
  • NM_000925.4:c.1069T>CMANE SELECT
  • NM_001173468.2:c.1015T>C
  • NM_001315536.2:c.1015T>C
  • NP_000916.2:p.Leu357=
  • NP_001166939.1:p.Leu339=
  • NP_001302465.1:p.Leu339=
  • NC_000003.11:g.58413772A>G
  • NC_000003.11:g.58413772A>G
  • NM_000925.3:c.1069T>C
  • NR_033384.2:n.1175T>C
Links:
Molecular consequence:
  • NR_033384.2:n.1175T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]
  • NM_000925.4:c.1069T>C - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001173468.2:c.1015T>C - synonymous variant - [Sequence Ontology: SO:0001819]
  • NM_001315536.2:c.1015T>C - synonymous variant - [Sequence Ontology: SO:0001819]

Condition(s)

Name:
Pyruvate dehydrogenase E1-beta deficiency (PDHBD)
Identifiers:
MONDO: MONDO:0013580; MedGen: C3279841; Orphanet: 255138; Orphanet: 765; OMIM: 614111

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001305503Illumina Clinical Services Laboratory,Illuminacriteria provided, single submitter
Uncertain significance
(Jan 12, 2018)
germlineclinical testing

Citation Link,

SCV001688037Invitaecriteria provided, single submitter
Likely benign
(Sep 3, 2020)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240-242.

PubMed [citation]
PMID:
28492532
PMCID:
PMC5632818

Details of each submission

From Illumina Clinical Services Laboratory,Illumina, SCV001305503.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Invitae, SCV001688037.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 24, 2021

Support Center